Topics

IPO Update: Pace Of US Offerings Slows As 13 Biopharmas Go Public In 2019

15:52 EDT 1 May 2019 | SCRIP

With about three IPOs per month compared with a pace of nearly six per month in 2018, drug developers have...

      

Related Stories

 

Original Article: IPO Update: Pace Of US Offerings Slows As 13 Biopharmas Go Public In 2019

NEXT ARTICLE

More From BioPortfolio on "IPO Update: Pace Of US Offerings Slows As 13 Biopharmas Go Public In 2019"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...